Top Markets
#1 Palladium Network Palladium Network +27.91%
#2 Ankr Network Ankr Network +25.74%
#3 Siren Siren +22.87%
#4 Status Status +13.69%
#5 BankrCoin BankrCoin +12.46%
#6 ICON ICON +11.78%
#7 WAX WAX +8.31%
#8 Wiki Cat Wiki Cat +7.36%
#9 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.04%
#10 would would +6.48%
Coin of the day
Palladium Network Palladium Network
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Organogenesis Holdings Inc. Organogenesis Holdings Inc.

Organogenesis Holdings Inc.

ORGO
Classificação em ações #17992
Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that... Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that specializes in creating, producing, and marketing innovative therapies for advanced wound management, as well as surgical and sports medicine applications. Within its advanced wound care portfolio, Organogenesis offers several distinct products. These include Affinity and Novachor, both amniotic membrane dressings designed to preserve vital cells, growth factors, and ECM proteins found in natural tissue. Apligraf is a bioengineered living cell therapy that releases a range of healing cytokines and growth factors, while Dermagraft is another bioengineered solution that generates human collagen, ECM, proteins, and cytokines. NuShield provides a wound covering incorporating both amnion and chorion membranes to maintain a spongy intermediate layer. PuraPly acts as an antimicrobial barrier, allowing for flexibility and effective fluid drainage. For the surgical and sports medicine sectors, the company provides products such as NuCel, a dehydrated placental tissue designed for surgical application to promote natural tissue regeneration. ReNu is a cryopreserved suspension aimed at aiding soft tissue recovery. Additionally, FiberOS and OCMP serve as bone void fillers, primarily utilized in orthopedic and neurosurgical procedures. Looking ahead, Organogenesis's product pipeline features PuraPly XT and PuraPly MZ, which are being developed for treating chronic, acute, and open wounds. PuraForce is a bioengineered porcine collagen surgical matrix intended for soft tissue reinforcement. TransCyte, another bioengineered tissue, is in development for addressing partial thickness burns. Organogenesis distributes its offerings to a diverse client base, including hospitals, specialized wound care centers, government institutions, ambulatory surgical centers, and physician offices, leveraging both its direct sales team and independent agencies. Established in 1985, the company maintains its headquarters in Canton, Massachusetts.
Preço da ação
$1.69
Última sincronização: 2026-09-02
Valor de mercado
$216.83M
Variação (1 dia)
3.38%
Variação (1 ano)
-66.03%
País
US
Negociar Organogenesis Holdings Inc. (ORGO)

Categoria

Healthcare
Histórico de preços das ações de Organogenesis Holdings Inc. (ORGO)
Preço de fecho mais alto: $1.66 em 2026-09-01

Preço de fecho mais baixo: $9.83 em 2017-01-01
Histórico de preços das ações da Organogenesis Holdings Inc. de 2017 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -33.06%
2025 49.27%
2024 -2.32%
2023 34.82%
2022 -72.75%
2021 64.32%
2020 18.91%
2019 -51.56%
2018 3.21%
2017 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 $171.67 -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 $165.17 29.24%
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 $38.45 26.55%
JP
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $21.28 18.70%
IN
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 $214.98 24.44%
CH